As the conversation around sustainable weight management evolves, a new treatment is gaining attention for its promising clinical results. Unlike many other weight-loss medications that are prescribed off-label or repurposed from diabetes treatments, this formulation of semaglutide has been approved by the U.S. Food and Drug Administration (FDA) for chronic weight management and has now been launched in Singapore.

Why This Treatment Stands Out Among Weight-Loss Options

This semaglutide injection is different from existing weight-loss medications. Most drugs used for weight loss today were originally developed for other purposes like diabetes. Doctors often prescribe them “off-label”. That means the drug was not officially approved for weight loss. In contrast, this injectable form of semaglutide is used in people with overweight and obesity to lose weight and reduce associated health risks, including cardiovascular disease. Clinical studies showed that patients lost about 15% of their body weight on average. That result is much higher than what older drugs typically achieve.

Semaglutide works by mimicking a naturally occurring hormone called GLP-1, which helps regulate appetite, food intake, and blood sugar. When semaglutide activates GLP-1 receptors in the body, it helps people feel full faster and stay full longer. As a result, patients eat less and lose weight steadily. This semaglutide is given as a once-weekly injection. That makes it easier to stick with the treatment. Many other options require daily dosing, which can be hard to maintain over time. The once-weekly schedule improves convenience and reduces the chance of missed doses.

A Closer Look: How It Compares to Other Weight-Loss Medications

When comparing this weekly semaglutide injection to other weight-loss drugs, the differences become even more pronounced. Oral semaglutide, for example, is typically used for managing type 2 diabetes, not weight loss. It also requires strict timing around meals and comes with lower weight-loss efficacy compared to the higher-dose injectable version. Liraglutide, another GLP-1 receptor agonist, has shown moderate weight loss in clinical trials—around 5% to 10% of total body weight. However, the daily schedule also makes it harder for patients to stay consistent. Other medicine like orlistat works by blocking fat absorption in the intestines. It can help people lose 2% to 5% of their weight. But the side effects are often unpleasant. Many people experience oily stools, bloating, or diarrhea. These issues make it hard to stay on the medication long term. Another medicine is phentermine which is a stimulant that suppresses appetite by acting on the brain. However, it is associated with potential side effects such as increased heart rate, insomnia, anxiety, and the risk of dependency. For these reasons, doctors often limit its use to a few weeks.

In contrast, semaglutide offers a more balanced profile. Clinical trials have shown average weight reductions of up to 15%, with individual results ranging from 5% (>80%) to 20%(about 32%), far surpassing other agents. In addition to weight loss, the medication has also demonstrated cardiovascular benefits in certain population. It works gradually to reduce food intake and body weight.

What About Side Effects?

As with any medication, this injectable semaglutide is not without side effects. The most common ones involve the digestive system. These include nausea, constipation, and diarrhea. These side effects usually appear in the early weeks and improve over time. Doctors often start with a low dose and increase it slowly. This helps reduce discomfort during the adjustment period. It comes in 5 different dose strengths, which are injected under the skin. The starting dose is 0.25 mg once a week, and you will gradually increase your dose every 4 weeks. Your health care professional can select either 1.7 mg or 2.4 mg for your maintenance dose. Importantly, semaglutide does not carry the heart or brain risks linked to stimulant drugs like phentermine. It also does not cause the oily stools or bowel urgency seen with orlistat. These safety benefits make it a good option for long-term use.

The New Frontier in Weight loss

Semaglutide injections mark a major step forward in the fight against obesity. It combines the convenience of weekly dosing, the regulatory assurance of FDA approval, and a robust clinical profile that sets it apart from previous generations of weight-loss medications. As always, patients should consult a licensed medical professional to determine if this treatment is appropriate for their health profile and weight-loss goals.